Injecto Polymers IPO: Date, Price, GMP & Review | Finowings

 The Injecto Polymers IPO is a book-built issue of ₹56.12 crore, comprising an entirely fresh issue of 56.12 lakh shares. The IPO opened for subscription on September 11, 2026, and will close on September 16, 2026. The company has fixed the IPO price band at ₹98 to ₹100 per share.

Injecto Polymers IPO GMP

The Injecto Polymers IPO GMP is an important indicator that investors may track to understand unofficial market sentiment around the issue. GMP can change depending on demand, subscription levels and overall market conditions.

Based on the upper price band of ₹100, retail investors need to apply for a minimum of 2,400 shares, requiring an investment of ₹2,40,000. The IPO lot size is 1,200 shares. HNI investors need to apply for at least 3 lots, or 3,600 shares, requiring ₹3,60,000 at the upper price band.

Investors should remember that GMP is unofficial and does not guarantee the actual listing price or returns.

Injecto Polymers IPO Allotment

The Injecto Polymers IPO allotment is expected to be finalized on September 17, 2026. Investors who have applied for the IPO can check their allotment status through the IPO registrar or relevant official platforms after the basis of allotment is completed.

Successful applicants are expected to receive the shares in their demat accounts around September 18, 2026, while the tentative listing date is September 21, 2026.

Injecto Polymers IPO Listing

Injecto Polymers shares are proposed to be listed on the BSE SME platform. Investors should monitor subscription figures, GMP trends, company fundamentals and broader market sentiment before making an investment decision.

Conclusion

The Injecto Polymers IPO GMP and allotment status are key updates for investors following the issue. Since GMP is unofficial and can fluctuate, investors should consider multiple factors rather than relying solely on grey-market trends.

Disclaimer: This article is for informational purposes only and should not be considered investment advice. Investors should conduct their own research before investing.

Finowings